These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27788040)

  • 41. Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze.
    Pulga A; Ruzza C; Rizzi A; Guerrini R; Calo G
    Eur J Neurosci; 2012 Dec; 36(11):3531-7. PubMed ID: 22928868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropeptide S promotes maintenance of newly formed dendritic spines and performance improvement after motor learning in mice.
    Li C; Wu XJ; Li W
    Peptides; 2022 Oct; 156():170860. PubMed ID: 35970276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropeptide S facilitates mice olfactory function through activation of cognate receptor-expressing neurons in the olfactory cortex.
    Shao YF; Zhao P; Dong CY; Li J; Kong XP; Wang HL; Dai LR; Hou YP
    PLoS One; 2013; 8(4):e62089. PubMed ID: 23614017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function.
    Clark SD; Tran HT; Zeng J; Reinscheid RK
    Peptides; 2010 Jan; 31(1):130-8. PubMed ID: 19874863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli.
    Dannlowski U; Kugel H; Franke F; Stuhrmann A; Hohoff C; Zwanzger P; Lenzen T; Grotegerd D; Suslow T; Arolt V; Heindel W; Domschke K
    Neuropsychopharmacology; 2011 Aug; 36(9):1879-85. PubMed ID: 21525857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ₁₋₄₂ in mice novel object and object location recognition tasks.
    Han RW; Zhang RS; Xu HJ; Chang M; Peng YL; Wang R
    Neuropharmacology; 2013 Jul; 70():261-7. PubMed ID: 23454528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system.
    Reinscheid RK; Xu YL
    Neuroscientist; 2005 Dec; 11(6):532-8. PubMed ID: 16282594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
    Roth AL; Marzola E; Rizzi A; Arduin M; Trapella C; Corti C; Vergura R; Martinelli P; Salvadori S; Regoli D; Corsi M; Cavanni P; Caló G; Guerrini R
    J Biol Chem; 2006 Jul; 281(30):20809-20816. PubMed ID: 16720571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Role for Neuropeptide S in Alcohol and Cocaine Seeking.
    Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Cifani C; De Carlo S; Domi E; Ubaldi M
    Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
    Vitale G; Filaferro M; Ruggieri V; Pennella S; Frigeri C; Rizzi A; Guerrini R; Calò G
    Peptides; 2008 Dec; 29(12):2286-91. PubMed ID: 18793688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide S: anatomy, pharmacology, genetics and physiological functions.
    Reinscheid RK
    Results Probl Cell Differ; 2008; 46():145-58. PubMed ID: 18204825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paradoxical response to the sedative effects of diazepam and alcohol in C57BL/6J mice lacking the neuropeptide S receptor.
    Ghazal P; Corsi M; Roth A; Faggioni F; Corti C; Merlo Pick E; Pucciarelli S; Ciccocioppo R; Ubaldi M
    Peptides; 2014 Nov; 61():107-13. PubMed ID: 25240770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel M(1) allosteric ligands: a patent review.
    Kuduk SD; Beshore DC
    Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.
    Tancredi T; Guerrini R; Marzola E; Trapella C; Calo G; Regoli D; Reinscheid RK; Camarda V; Salvadori S; Temussi PA
    J Med Chem; 2007 Sep; 50(18):4501-8. PubMed ID: 17696420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropeptide S produces antinociceptive effects at the supraspinal level in mice.
    Li W; Chang M; Peng YL; Gao YH; Zhang JN; Han RW; Wang R
    Regul Pept; 2009 Aug; 156(1-3):90-5. PubMed ID: 19345242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
    Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Vittori S; Volpini R; Cristalli G
    ChemMedChem; 2010 Mar; 5(3):371-83. PubMed ID: 20087922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.
    Okamura N; Habay SA; Zeng J; Chamberlin AR; Reinscheid RK
    J Pharmacol Exp Ther; 2008 Jun; 325(3):893-901. PubMed ID: 18337476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The regulatory role of central neuropeptide-S in locomotion.
    Akçalı İ; Akkan SS; Bülbül M
    Peptides; 2023 Dec; 170():171110. PubMed ID: 37832875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Orexin receptor antagonists: a review of promising compounds patented since 2006.
    Coleman PJ; Renger JJ
    Expert Opin Ther Pat; 2010 Mar; 20(3):307-24. PubMed ID: 20180618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histamine H4 receptor ligands and their potential therapeutic applications: an update.
    Kiss R; Keserű GM
    Expert Opin Ther Pat; 2012 Mar; 22(3):205-21. PubMed ID: 22385042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.